334 related articles for article (PubMed ID: 34462564)
1. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
3. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N
Zhou J; Zhu Y; Ai D; Zhou M; Li H; Li G; Zheng L; Song J
J Transl Med; 2023 Nov; 21(1):781. PubMed ID: 37925419
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO inhibits glucocorticoid-induced osteoblast differentiation and function in bone marrow mesenchymal stem cells.
Feng L; Zhao W; Fan Y; Yuan C; Zhang X
J Cell Biochem; 2023 Nov; 124(11):1835-1847. PubMed ID: 37882437
[TBL] [Abstract][Full Text] [Related]
6. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
8. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
9. FTO-Dependent
Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
[No Abstract] [Full Text] [Related]
10. TNF-α suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m
Wang Y; Wang R; Yao B; Hu T; Li Z; Liu Y; Cui X; Cheng L; Song W; Huang S; Fu X
Sci China Life Sci; 2020 Jan; 63(1):80-91. PubMed ID: 31637575
[TBL] [Abstract][Full Text] [Related]
11. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
12. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
13. The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.
Xu M; Li B; Huang J; Jia R; Guo J
Int Endod J; 2023 Dec; 56(12):1534-1549. PubMed ID: 37698901
[TBL] [Abstract][Full Text] [Related]
14. Mettl3-mediated m
Wu Y; Xie L; Wang M; Xiong Q; Guo Y; Liang Y; Li J; Sheng R; Deng P; Wang Y; Zheng R; Jiang Y; Ye L; Chen Q; Zhou X; Lin S; Yuan Q
Nat Commun; 2018 Nov; 9(1):4772. PubMed ID: 30429466
[TBL] [Abstract][Full Text] [Related]
15. Autophagy receptor OPTN (optineurin) regulates mesenchymal stem cell fate and bone-fat balance during aging by clearing FABP3.
Liu ZZ; Hong CG; Hu WB; Chen ML; Duan R; Li HM; Yue T; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Xu L; Tang SY; Hu RG; Xie H
Autophagy; 2021 Oct; 17(10):2766-2782. PubMed ID: 33143524
[TBL] [Abstract][Full Text] [Related]
16. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
17. Fat mass and obesity-associated protein (FTO) affects midpalatal suture bone remodeling during rapid maxillary expansion.
Zhao T; Tao Z; Zhang G; Zhu J; Du M; Hua F; He H
Eur J Orthod; 2024 Apr; 46(2):. PubMed ID: 38376496
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibition.
Zhang X; Wang Y; Zhao H; Han X; Zhao T; Qu P; Li G; Wang W
Stem Cell Res Ther; 2020 Jun; 11(1):227. PubMed ID: 32522250
[TBL] [Abstract][Full Text] [Related]
19. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
[TBL] [Abstract][Full Text] [Related]
20. The N
Li Z; Wang P; Li J; Xie Z; Cen S; Li M; Liu W; Ye G; Zheng G; Ma M; Wang S; Yu W; Wu Y; Shen H
Cell Death Dis; 2021 Jun; 12(6):578. PubMed ID: 34088896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
